治療用酵素のグローバル市場(~2027):キチナーゼ、アスパルギナーゼ、その他

◆英語タイトル:Therapeutics Enzymes Market Forecasts to 2028 – Global Analysis By Product Type (Chitinase, Asparginase and Other Product Types), By Application (Leukemia, Stomach Disorders and Other Applications), By End User (Drug manufacturers, Hospitals, Private clinics and Research laboratories) and Geography

Stratistics MRCが発行した調査報告書(SMR23MR052)◆商品コード:SMR23MR052
◆発行会社(リサーチ会社):Stratistics MRC
◆発行日:2022年12月
◆ページ数:約150
◆レポート形式:英語 / Eメール
◆納品方法:英語
◆調査対象地域:グローバル
◆産業分野:化学
◆販売価格オプション(消費税別)
Global Site LicenseUSD4,150 ⇒換算¥630,800見積依頼/購入/質問フォーム
PDFUSD7,500 ⇒換算¥1,140,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可)

❖ レポートの概要 ❖

Stratistics MRC社の本調査レポートでは、世界の治療用酵素市場規模が2022年に8467.9百万ドルから2028年には18684.8百万ドルに上り、予測期間中にCAGR 14.1%で成長すると展望しています。本書では、治療用酵素の世界市場について徹底的に調査・分析を行い、エグゼクティブサマリー、序論、市場動向分析、ファイブフォース分析、製品種類別(キチナーゼ、アスパルギナーゼ、その他)分析、用途別(白血病、胃疾患、その他)分析、エンドユーザー別(製薬会社、病院、私立診療所、研究所)分析、地域別(北米、ヨーロッパ、アジア太平洋、南米、中東・アフリカ)分析、最近の動向、企業情報などを考察しています。また、Sanofi, BioMarin, AbbVie, F. Hoffmann-La Roche Ltd,Thermo Fisher Scientific Inc., Alexion, DSM, Novozymes, Horizon Pharma, Allergan, Johnson and Johnson , Alexion Pharmaceuticals Inc, Pfizer Inc.などの企業情報を収録しています。
・エグゼクティブサマリー
・序論
・市場動向分析
・ファイブフォース分析
・世界の治療用酵素市場規模:製品種類別
- キチナーゼの市場規模
- アスパルギナーゼの市場規模
- その他製品の市場規模
・世界の治療用酵素市場規模:用途別
- 白血病治療用酵素の市場規模
- 胃疾患治療用酵素の市場規模
- その他用途の市場規模
・世界の治療用酵素市場規模:エンドユーザー別
- 製薬会社における市場規模
- 病院における市場規模
- 私立診療所における市場規模
- 研究所における市場規模
・世界の治療用酵素市場規模:地域別
- 北米の治療用酵素市場規模
- ヨーロッパの治療用酵素市場規模
- アジア太平洋の治療用酵素市場規模
- 南米の治療用酵素市場規模
- 中東・アフリカの治療用酵素市場規模
・最近の動向
・企業情報

Stratistics MRCによると、世界の治療用酵素市場は2022年に8億4679万ドルを占め、予測期間中の年平均成長率は14.1%で、2028年には1億8684万ドルに達する見込みです。酵素と生体触媒は、食物のタンパク質を消化して得られるアミノ酸から人体内で生成されます。治療用酵素は、医療目的で使用される酵素のサブセットで、結合型または単離型のいずれかになります。これらの酵素は、血栓溶解剤、腫瘍溶解剤、抗凝固剤、特定の代謝不全の代替物など、幅広い用途があります。白血病、その他の癌、心血管系疾患、皮膚潰瘍、その他の疾患に対する患者数の増加、ストレスの増加の原因となる座りがちなライフスタイルの増加、それに伴う医療サービスの向上などがあります。

米国がん協会によると、2016年には米国だけで168万5,210人が新たにがんと診断されたと予想され、世界保健機関(WHO)の報告によると、2015年には世界で1,770万人が心血管疾患で死亡しています。このデータは、がんおよび心血管治療薬の市場ポテンシャルを示しています。治療用酵素は両疾患の治療において重要であるため、予測期間中にその使用量は増加すると予想されます。

市場の主要企業

治療用酵素市場の主要企業には、Sanofi, BioMarin, AbbVie, F. Hoffmann-La Roche Ltd,Thermo Fisher Scientific Inc., Alexion, DSM, Novozymes, Horizon Pharma, Allergan, Johnson and Johnson , Alexion Pharmaceuticals Inc, Pfizer Inc., Vivus, Digestive Care, Leadiant Biosciences, Roche Holdings AG and Codexis Inc.が含まれます。

主な展開

2020年1月、CodexisとNestlé Health Scienceは、消化器疾患の潜在的治療のための新しい酵素療法を発見することを目的とした戦略的提携を締結しました。

2018年10月、Leadiant Biosciences, Inc.は小児および成人患者におけるアデノシンデアミナーゼ重症複合免疫不全症(ADA-SCID)治療用酵素補充療法であるRevcoviのUSFDA承認を取得しました。

対象製品
– キチナーゼ
– アスパルギナーゼ
– リパーゼ
– プロテアーゼ
– ナットウキナーゼ
– セラチオペプチダーゼ
– コラゲナーゼ
– リガーゼ
– その他の製品タイプ

対象となるアプリケーション
– 白血病
– 胃疾患
– 抗腫瘍
– 皮膚潰瘍
– ゴーシェ病
– ファブリー病
– その他の用途

対象エンドユーザー
– 医薬品メーカー
– 病院
– 個人クリニック
– 研究所

対象地域
– 北米
米国
カナダ
メキシコ
– ヨーロッパ
ドイツ
英国
イタリア
フランス
スペイン
その他のヨーロッパ
– アジア太平洋
日本
中国
インド
オーストラリア
ニュージーランド
韓国
その他のアジア太平洋地域
– 南米
アルゼンチン
ブラジル
チリ
その他の南米諸国
– 中東・アフリカ
サウジアラビア
アラブ首長国連邦
カタール
南アフリカ
その他の中東・アフリカ

❖ レポートの目次 ❖

1 Executive Summary
2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions
3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Product Analysis
3.7 Application Analysis
3.8 End User Analysis
3.9 Emerging Markets
3.10 Impact of Covid-19
4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry
5 Global Therapeutic Enzymes Market, By Product Type
5.1 Introduction
5.2 Chitinase
5.3 Asparginase
5.4 Lipase
5.5 Protease
5.6 Nattokinase
5.7 Serratiopeptidase
5.8 Collagenase
5.9 Ligase
5.10 Other Product Types
6 Global Therapeutic Enzymes Market, By Application
6.1 Introduction
6.2 Leukemia
6.3 Stomach Disorders
6.4 Antitumor
6.5 Skin Ulcers
6.6 Gaucher disease
6.7 Fabry disease
6.8 Other Applications
7 Global Therapeutic Enzymes Market, End User
7.1 Introduction
7.2 Drug manufacturers
7.3 Hospitals
7.4 Private clinics
7.5 Research laboratories
8 Global Therapeutic Enzymes Market, By Geography
8.1 Introduction
8.2 North America
8.2.1 US
8.2.2 Canada
8.2.3 Mexico
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 Italy
8.3.4 France
8.3.5 Spain
8.3.6 Rest of Europe
8.4 Asia Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Australia
8.4.5 New Zealand
8.4.6 South Korea
8.4.7 Rest of Asia Pacific
8.5 South America
8.5.1 Argentina
8.5.2 Brazil
8.5.3 Chile
8.5.4 Rest of South America
8.6 Middle East & Africa
8.6.1 Saudi Arabia
8.6.2 UAE
8.6.3 Qatar
8.6.4 South Africa
8.6.5 Rest of Middle East & Africa
9 Key Developments
9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies
10 Company Profiling
10.1 Sanofi
10.2 BioMarin
10.3 AbbVie
10.4 F. Hoffmann-La Roche Ltd
10.5 Thermo Fisher Scientific Inc.
10.6 Alexion
10.7 DSM
10.8 Novozymes
10.9 Horizon Pharma
10.10 Allergan
10.11 Johnson and Johnson
10.12 Alexion Pharmaceuticals Inc
10.13 Pfizer Inc.
10.14 Vivus, Digestive Care
10.15 Leadiant Biosciences
10.16 Roche Holdings AG
10.17 Codexis Inc.
List of Tables
Table 1 Global Therapeutic Enzymes Market Outlook, By Region (2020-2028) ($MN)
Table 2 Global Therapeutic Enzymes Market Outlook, By Product Type (2020-2028) ($MN)
Table 3 Global Therapeutic Enzymes Market Outlook, By Chitinase (2020-2028) ($MN)
Table 4 Global Therapeutic Enzymes Market Outlook, By Asparginase (2020-2028) ($MN)
Table 5 Global Therapeutic Enzymes Market Outlook, By Lipase (2020-2028) ($MN)
Table 6 Global Therapeutic Enzymes Market Outlook, By Protease (2020-2028) ($MN)
Table 7 Global Therapeutic Enzymes Market Outlook, By Nattokinase (2020-2028) ($MN)
Table 8 Global Therapeutic Enzymes Market Outlook, By Serratiopeptidase (2020-2028) ($MN)
Table 9 Global Therapeutic Enzymes Market Outlook, By Collagenase (2020-2028) ($MN)
Table 10 Global Therapeutic Enzymes Market Outlook, By Ligase (2020-2028) ($MN)
Table 11 Global Therapeutic Enzymes Market Outlook, By Other Product Types (2020-2028) ($MN)
Table 12 Global Therapeutic Enzymes Market Outlook, By Application (2020-2028) ($MN)
Table 13 Global Therapeutic Enzymes Market Outlook, By Leukemia (2020-2028) ($MN)
Table 14 Global Therapeutic Enzymes Market Outlook, By Stomach Disorders (2020-2028) ($MN)
Table 15 Global Therapeutic Enzymes Market Outlook, By Antitumor (2020-2028) ($MN)
Table 16 Global Therapeutic Enzymes Market Outlook, By Skin Ulcers (2020-2028) ($MN)
Table 17 Global Therapeutic Enzymes Market Outlook, By Gaucher disease (2020-2028) ($MN)
Table 18 Global Therapeutic Enzymes Market Outlook, By Fabry disease (2020-2028) ($MN)
Table 19 Global Therapeutic Enzymes Market Outlook, By Other Application (2020-2028) ($MN)
Table 20 Global Therapeutic Enzymes Market Outlook, By End User (2020-2028) ($MN)
Table 21 Global Therapeutic Enzymes Market Outlook, By Drug manufacturers (2020-2028) ($MN)
Table 22 Global Therapeutic Enzymes Market Outlook, By Hospitals (2020-2028) ($MN)
Table 23 Global Therapeutic Enzymes Market Outlook, By Private clinics (2020-2028) ($MN)
Table 24 Global Therapeutic Enzymes Market Outlook, By Research laboratories (2020-2028) ($MN)
Table 25 North America Therapeutic Enzymes Market Outlook, By Country (2020-2028) ($MN)
Table 26 North America Therapeutic Enzymes Market Outlook, By Product Type (2020-2028) ($MN)
Table 27 North America Therapeutic Enzymes Market Outlook, By Chitinase (2020-2028) ($MN)
Table 28 North America Therapeutic Enzymes Market Outlook, By Asparginase (2020-2028) ($MN)
Table 29 North America Therapeutic Enzymes Market Outlook, By Lipase (2020-2028) ($MN)
Table 30 North America Therapeutic Enzymes Market Outlook, By Protease (2020-2028) ($MN)
Table 31 North America Therapeutic Enzymes Market Outlook, By Nattokinase (2020-2028) ($MN)
Table 32 North America Therapeutic Enzymes Market Outlook, By Serratiopeptidase (2020-2028) ($MN)
Table 33 North America Therapeutic Enzymes Market Outlook, By Collagenase (2020-2028) ($MN)
Table 34 North America Therapeutic Enzymes Market Outlook, By Ligase (2020-2028) ($MN)
Table 35 North America Therapeutic Enzymes Market Outlook, By Other Product Types (2020-2028) ($MN)
Table 36 North America Therapeutic Enzymes Market Outlook, By Application (2020-2028) ($MN)
Table 37 North America Therapeutic Enzymes Market Outlook, By Leukemia (2020-2028) ($MN)
Table 38 North America Therapeutic Enzymes Market Outlook, By Stomach Disorders (2020-2028) ($MN)
Table 39 North America Therapeutic Enzymes Market Outlook, By Antitumor (2020-2028) ($MN)
Table 40 North America Therapeutic Enzymes Market Outlook, By Skin Ulcers (2020-2028) ($MN)
Table 41 North America Therapeutic Enzymes Market Outlook, By Gaucher disease (2020-2028) ($MN)
Table 42 North America Therapeutic Enzymes Market Outlook, By Fabry disease (2020-2028) ($MN)
Table 43 North America Therapeutic Enzymes Market Outlook, By Other Application (2020-2028) ($MN)
Table 44 North America Therapeutic Enzymes Market Outlook, By End User (2020-2028) ($MN)
Table 45 North America Therapeutic Enzymes Market Outlook, By Drug manufacturers (2020-2028) ($MN)
Table 46 North America Therapeutic Enzymes Market Outlook, By Hospitals (2020-2028) ($MN)
Table 47 North America Therapeutic Enzymes Market Outlook, By Private clinics (2020-2028) ($MN)
Table 48 North America Therapeutic Enzymes Market Outlook, By Research laboratories (2020-2028) ($MN)
Table 49 Europe Therapeutic Enzymes Market Outlook, By Country (2020-2028) ($MN)
Table 50 Europe Therapeutic Enzymes Market Outlook, By Product Type (2020-2028) ($MN)
Table 51 Europe Therapeutic Enzymes Market Outlook, By Chitinase (2020-2028) ($MN)
Table 52 Europe Therapeutic Enzymes Market Outlook, By Asparginase (2020-2028) ($MN)
Table 53 Europe Therapeutic Enzymes Market Outlook, By Lipase (2020-2028) ($MN)
Table 54 Europe Therapeutic Enzymes Market Outlook, By Protease (2020-2028) ($MN)
Table 55 Europe Therapeutic Enzymes Market Outlook, By Nattokinase (2020-2028) ($MN)
Table 56 Europe Therapeutic Enzymes Market Outlook, By Serratiopeptidase (2020-2028) ($MN)
Table 57 Europe Therapeutic Enzymes Market Outlook, By Collagenase (2020-2028) ($MN)
Table 58 Europe Therapeutic Enzymes Market Outlook, By Ligase (2020-2028) ($MN)
Table 59 Europe Therapeutic Enzymes Market Outlook, By Other Product Types (2020-2028) ($MN)
Table 60 Europe Therapeutic Enzymes Market Outlook, By Application (2020-2028) ($MN)
Table 61 Europe Therapeutic Enzymes Market Outlook, By Leukemia (2020-2028) ($MN)
Table 62 Europe Therapeutic Enzymes Market Outlook, By Stomach Disorders (2020-2028) ($MN)
Table 63 Europe Therapeutic Enzymes Market Outlook, By Antitumor (2020-2028) ($MN)
Table 64 Europe Therapeutic Enzymes Market Outlook, By Skin Ulcers (2020-2028) ($MN)
Table 65 Europe Therapeutic Enzymes Market Outlook, By Gaucher disease (2020-2028) ($MN)
Table 66 Europe Therapeutic Enzymes Market Outlook, By Fabry disease (2020-2028) ($MN)
Table 67 Europe Therapeutic Enzymes Market Outlook, By Other Application (2020-2028) ($MN)
Table 68 Europe Therapeutic Enzymes Market Outlook, By End User (2020-2028) ($MN)
Table 69 Europe Therapeutic Enzymes Market Outlook, By Drug manufacturers (2020-2028) ($MN)
Table 70 Europe Therapeutic Enzymes Market Outlook, By Hospitals (2020-2028) ($MN)
Table 71 Europe Therapeutic Enzymes Market Outlook, By Private clinics (2020-2028) ($MN)
Table 72 Europe Therapeutic Enzymes Market Outlook, By Research laboratories (2020-2028) ($MN)
Table 73 Asia Pacific Therapeutic Enzymes Market Outlook, By Country (2020-2028) ($MN)
Table 74 Asia Pacific Therapeutic Enzymes Market Outlook, By Product Type (2020-2028) ($MN)
Table 75 Asia Pacific Therapeutic Enzymes Market Outlook, By Chitinase (2020-2028) ($MN)
Table 76 Asia Pacific Therapeutic Enzymes Market Outlook, By Asparginase (2020-2028) ($MN)
Table 77 Asia Pacific Therapeutic Enzymes Market Outlook, By Lipase (2020-2028) ($MN)
Table 78 Asia Pacific Therapeutic Enzymes Market Outlook, By Protease (2020-2028) ($MN)
Table 79 Asia Pacific Therapeutic Enzymes Market Outlook, By Nattokinase (2020-2028) ($MN)
Table 80 Asia Pacific Therapeutic Enzymes Market Outlook, By Serratiopeptidase (2020-2028) ($MN)
Table 81 Asia Pacific Therapeutic Enzymes Market Outlook, By Collagenase (2020-2028) ($MN)
Table 82 Asia Pacific Therapeutic Enzymes Market Outlook, By Ligase (2020-2028) ($MN)
Table 83 Asia Pacific Therapeutic Enzymes Market Outlook, By Other Product Types (2020-2028) ($MN)
Table 84 Asia Pacific Therapeutic Enzymes Market Outlook, By Application (2020-2028) ($MN)
Table 85 Asia Pacific Therapeutic Enzymes Market Outlook, By Leukemia (2020-2028) ($MN)
Table 86 Asia Pacific Therapeutic Enzymes Market Outlook, By Stomach Disorders (2020-2028) ($MN)
Table 87 Asia Pacific Therapeutic Enzymes Market Outlook, By Antitumor (2020-2028) ($MN)
Table 88 Asia Pacific Therapeutic Enzymes Market Outlook, By Skin Ulcers (2020-2028) ($MN)
Table 89 Asia Pacific Therapeutic Enzymes Market Outlook, By Gaucher disease (2020-2028) ($MN)
Table 90 Asia Pacific Therapeutic Enzymes Market Outlook, By Fabry disease (2020-2028) ($MN)
Table 91 Asia Pacific Therapeutic Enzymes Market Outlook, By Other Application (2020-2028) ($MN)
Table 92 Asia Pacific Therapeutic Enzymes Market Outlook, By End User (2020-2028) ($MN)
Table 93 Asia Pacific Therapeutic Enzymes Market Outlook, By Drug manufacturers (2020-2028) ($MN)
Table 94 Asia Pacific Therapeutic Enzymes Market Outlook, By Hospitals (2020-2028) ($MN)
Table 95 Asia Pacific Therapeutic Enzymes Market Outlook, By Private clinics (2020-2028) ($MN)
Table 96 Asia Pacific Therapeutic Enzymes Market Outlook, By Research laboratories (2020-2028) ($MN)
Table 97 South America Therapeutic Enzymes Market Outlook, By Country (2020-2028) ($MN)
Table 98 South America Therapeutic Enzymes Market Outlook, By Product Type (2020-2028) ($MN)
Table 99 South America Therapeutic Enzymes Market Outlook, By Chitinase (2020-2028) ($MN)
Table 100 South America Therapeutic Enzymes Market Outlook, By Asparginase (2020-2028) ($MN)
Table 101 South America Therapeutic Enzymes Market Outlook, By Lipase (2020-2028) ($MN)
Table 102 South America Therapeutic Enzymes Market Outlook, By Protease (2020-2028) ($MN)
Table 103 South America Therapeutic Enzymes Market Outlook, By Nattokinase (2020-2028) ($MN)
Table 104 South America Therapeutic Enzymes Market Outlook, By Serratiopeptidase (2020-2028) ($MN)
Table 105 South America Therapeutic Enzymes Market Outlook, By Collagenase (2020-2028) ($MN)
Table 106 South America Therapeutic Enzymes Market Outlook, By Ligase (2020-2028) ($MN)
Table 107 South America Therapeutic Enzymes Market Outlook, By Other Product Types (2020-2028) ($MN)
Table 108 South America Therapeutic Enzymes Market Outlook, By Application (2020-2028) ($MN)
Table 109 South America Therapeutic Enzymes Market Outlook, By Leukemia (2020-2028) ($MN)
Table 110 South America Therapeutic Enzymes Market Outlook, By Stomach Disorders (2020-2028) ($MN)
Table 111 South America Therapeutic Enzymes Market Outlook, By Antitumor (2020-2028) ($MN)
Table 112 South America Therapeutic Enzymes Market Outlook, By Skin Ulcers (2020-2028) ($MN)
Table 113 South America Therapeutic Enzymes Market Outlook, By Gaucher disease (2020-2028) ($MN)
Table 114 South America Therapeutic Enzymes Market Outlook, By Fabry disease (2020-2028) ($MN)
Table 115 South America Therapeutic Enzymes Market Outlook, By Other Application (2020-2028) ($MN)
Table 116 South America Therapeutic Enzymes Market Outlook, By End User (2020-2028) ($MN)
Table 117 South America Therapeutic Enzymes Market Outlook, By Drug manufacturers (2020-2028) ($MN)
Table 118 South America Therapeutic Enzymes Market Outlook, By Hospitals (2020-2028) ($MN)
Table 119 South America Therapeutic Enzymes Market Outlook, By Private clinics (2020-2028) ($MN)
Table 120 South America Therapeutic Enzymes Market Outlook, By Research laboratories (2020-2028) ($MN)
Table 121 Middle East & Africa Therapeutic Enzymes Market Outlook, By Country (2020-2028) ($MN)
Table 122 Middle East & Africa Therapeutic Enzymes Market Outlook, By Product Type (2020-2028) ($MN)
Table 123 Middle East & Africa Therapeutic Enzymes Market Outlook, By Chitinase (2020-2028) ($MN)
Table 124 Middle East & Africa Therapeutic Enzymes Market Outlook, By Asparginase (2020-2028) ($MN)
Table 125 Middle East & Africa Therapeutic Enzymes Market Outlook, By Lipase (2020-2028) ($MN)
Table 126 Middle East & Africa Therapeutic Enzymes Market Outlook, By Protease (2020-2028) ($MN)
Table 127 Middle East & Africa Therapeutic Enzymes Market Outlook, By Nattokinase (2020-2028) ($MN)
Table 128 Middle East & Africa Therapeutic Enzymes Market Outlook, By Serratiopeptidase (2020-2028) ($MN)
Table 129 Middle East & Africa Therapeutic Enzymes Market Outlook, By Collagenase (2020-2028) ($MN)
Table 130 Middle East & Africa Therapeutic Enzymes Market Outlook, By Ligase (2020-2028) ($MN)
Table 131 Middle East & Africa Therapeutic Enzymes Market Outlook, By Other Product Types (2020-2028) ($MN)
Table 132 Middle East & Africa Therapeutic Enzymes Market Outlook, By Application (2020-2028) ($MN)
Table 133 Middle East & Africa Therapeutic Enzymes Market Outlook, By Leukemia (2020-2028) ($MN)
Table 134 Middle East & Africa Therapeutic Enzymes Market Outlook, By Stomach Disorders (2020-2028) ($MN)
Table 135 Middle East & Africa Therapeutic Enzymes Market Outlook, By Antitumor (2020-2028) ($MN)
Table 136 Middle East & Africa Therapeutic Enzymes Market Outlook, By Skin Ulcers (2020-2028) ($MN)
Table 137 Middle East & Africa Therapeutic Enzymes Market Outlook, By Gaucher disease (2020-2028) ($MN)
Table 138 Middle East & Africa Therapeutic Enzymes Market Outlook, By Fabry disease (2020-2028) ($MN)
Table 139 Middle East & Africa Therapeutic Enzymes Market Outlook, By Other Application (2020-2028) ($MN)
Table 140 Middle East & Africa Therapeutic Enzymes Market Outlook, By End User (2020-2028) ($MN)
Table 141 Middle East & Africa Therapeutic Enzymes Market Outlook, By Drug manufacturers (2020-2028) ($MN)
Table 142 Middle East & Africa Therapeutic Enzymes Market Outlook, By Hospitals (2020-2028) ($MN)
Table 143 Middle East & Africa Therapeutic Enzymes Market Outlook, By Private clinics (2020-2028) ($MN)
Table 144 Middle East & Africa Therapeutic Enzymes Market Outlook, By Research laboratories (2020-2028) ($MN)



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 治療用酵素のグローバル市場(~2027):キチナーゼ、アスパルギナーゼ、その他(Therapeutics Enzymes Market Forecasts to 2028 – Global Analysis By Product Type (Chitinase, Asparginase and Other Product Types), By Application (Leukemia, Stomach Disorders and Other Applications), By End User (Drug manufacturers, Hospitals, Private clinics and Research laboratories) and Geography)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆